Authors: Underhill, CR Parnis, FX Highley, MS Ahern, J Harper, PG Hansen, H Lund, B Dombernowsky, P Hirsch, F Hansen, M Carmichael, J Williams, C

Citation: Cr. Underhill et al., Multicenter phase II study of gemcitabine in previously untreated patientswith advanced epithelial ovarian cancer, ANTI-CANC D, 12(8), 2001, pp. 647-652

Authors: Parnis, FX Olver, IN Kotasek, D Norman, J Taylor, A Russell, J Patterson, K Keefe, D Marafioti, T

Citation: Fx. Parnis et al., Phase II study of epirubicin, cisplatin and continuous infusion 5-fluorouracil (ECF) for carcinoma of unknown primary site, ANN ONCOL, 11(7), 2000, pp. 883-884

Authors: Highley, MS Underhill, CR Parnis, FX Karapetis, C Rankin, E Dussek, J Bryant, B Rowland, C Hodson, N Hughes, J Harper, PG

Citation: Ms. Highley et al., Treatment of invasive thymoma with single-agent ifosfamide, J CL ONCOL, 17(9), 1999, pp. 2737-2744